Join Now

Category Archives: BioUtah News

Recursion Appoints David Mauro, M.D., Ph.D., as Chief Medical Officer

SALT LAKE CITY, May 16, 2023 (GLOBE NEWSWIRE) — Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced it has appointed David Mauro, M.D., Ph.D, as its Chief Medical Officer. Dr. Mauro will lead Recursion’s pipeline into and through clinical development, including its five programs currently in […]

| Comments Off on Recursion Appoints David Mauro, M.D., Ph.D., as Chief Medical Officer

Nusano and PharmaLogic Announce Collaboration to Enable Next Generation Radiotherapeutics Development

SALT LAKE CITY and BOCA RATON, Fla. – May 15, 2023 – Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, and PharmaLogic, a world-class contract development and manufacturing organization (CDMO) specializing in radiopharmaceuticals, today announced the two organizations will collaborate to advance the development of radiopharmaceuticals for diagnostic and therapeutic applications.   “PharmaLogic […]

| Comments Off on Nusano and PharmaLogic Announce Collaboration to Enable Next Generation Radiotherapeutics Development

EY Announces Marcus Gerhardt and Florian Solzbacher of Blackrock Neurotech as Entrepreneur Of The Year® 2023 Mountain West Award Finalists

SALT LAKE CITY, May 8, 2023 – Ernst & Young LLP (EY US) today announced that Marcus Gerhardt, co-founder and CEO, and Florian Solzbacher, co-founder and President, of Blackrock Neurotech were named Entrepreneur Of The Year® 2023 Mountain West Award finalists. Now in its 37th year, Entrepreneur Of The Year is one of the preeminent […]

| Comments Off on EY Announces Marcus Gerhardt and Florian Solzbacher of Blackrock Neurotech as Entrepreneur Of The Year® 2023 Mountain West Award Finalists

NUSANO ANNOUNCES IN-HOUSE STABLE ISOTOPE PROGRAM LED BY RENOWNED PHYSICIST SARKO CHEREKDJIAN

VALENCIA, Calif. and WEST VALLEY CITY, Utah – May 11, 2023 – Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, today announced it is creating an in-house stable isotope program to enhance the company’s medical radioisotope production capabilities and decrease dependence on foreign supply chains. “Enriched, stable isotopes are foundational material for manufacturing […]

| Comments Off on NUSANO ANNOUNCES IN-HOUSE STABLE ISOTOPE PROGRAM LED BY RENOWNED PHYSICIST SARKO CHEREKDJIAN

Foldax, Inc. Receives Full Ownership Rights to Proprietary Polymer Patent Portfolio

SALT LAKE CITY–(BUSINESS WIRE)–Foldax® Inc. today announced that it has executed an agreement with Australia’s national science agency, CSIRO, for full ownership of a polymer technology patent family. Foldax has incorporated the polymer technology into its LifePolymer™ materials platform and has conducted testing, which indicates the materials are compatible with blood, with low adherence of […]

| Comments Off on Foldax, Inc. Receives Full Ownership Rights to Proprietary Polymer Patent Portfolio

Bruce Hunter named new Interim Chief Innovation and Economic Engagement Officer

By Xoel Cardenas, Sr. Communications Specialist, Office of the Vice President for Research The Partners for Innovation, Ventures, Outreach & Technology (PIVOT) Center at the University of Utah has named Bruce Hunter as the Interim Chief Innovation and Economic Engagement Officer. Hunter succeeds the role from Dr. Keith Marmer, who served as a leader for the university’s […]

| Comments Off on Bruce Hunter named new Interim Chief Innovation and Economic Engagement Officer

Recursion Enters into Agreements to Acquire Cyclica and Valence to Bolster Chemistry and Generative AI Capabilities

SALT LAKE CITY and TORONTO and MONTRÉAL, May 08, 2023 (GLOBE NEWSWIRE) — Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced it has signed agreements to acquire two companies in the AI-enabled drug discovery space: Cyclica and Valence. “Recursion has pioneered the massive, parallel generation of […]

| Comments Off on Recursion Enters into Agreements to Acquire Cyclica and Valence to Bolster Chemistry and Generative AI Capabilities

Vistim Labs Closes First Round of Funding

Vistim Labs Closes First Round of Funding

| Tagged | Comments Off on Vistim Labs Closes First Round of Funding

Culmination Bio and Cofactor Genomics Leverage Largest Biobank in the U.S. for PREDAPT Precision Medicine Clinical Trial

Respective leaders in healthcare innovation and RNA diagnostics team up to identify patients who will benefit from immunotherapy

| Tagged | Comments Off on Culmination Bio and Cofactor Genomics Leverage Largest Biobank in the U.S. for PREDAPT Precision Medicine Clinical Trial

BD Recognized by DiversityInc as a Top U.S. Company for Diversity in 2023 List

FRANKLIN LAKES, N.J., May 3, 2023 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has been named a “Noteworthy Company” in DiversityInc’s annual ranking of the top U.S. companies for diversity. Since 2001, the DiversityInc Top 50 survey has been the external validator for […]

| Comments Off on BD Recognized by DiversityInc as a Top U.S. Company for Diversity in 2023 List

Ultradent Adds 168,000 Sq. Ft. Facility to Campus

Ultradent Products, Inc., a leading developer and manufacturer of high-tech dental materials and equipment, is unveiling a new 168,000 sq. ft. facility on its South Jordan campus.   The building’s grand opening will feature a 10am MST ribbon cutting on May 3, 2023. Ultradent’s leadership, along with South Jordan Mayor Dawn Ramsey, as well as […]

| Comments Off on Ultradent Adds 168,000 Sq. Ft. Facility to Campus

Clinical Study Results of the BlueWind System for Patients with Overactive Bladder Featured at the 2023 AUA Annual Meeting

NEWS PROVIDED BY BlueWind Medical OASIS study achieves primary and secondary endpoints, safely mitigating the debilitating effects of urgency urinary incontinence Study results show that 78% of those implanted and 82% of patients completing the study achieved at least a 50% reduction in urge incontinence episodes at 12 months At 12 months, 50% of the […]

| Comments Off on Clinical Study Results of the BlueWind System for Patients with Overactive Bladder Featured at the 2023 AUA Annual Meeting